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Moreover, a haplotype consisting of the four minor alleles 
also had a protective effect on PSC susceptibility (p = 0.0084, 
OR 0.28). A haplotype of the four major alleles was inde-
pendently associated with PSC when excluding the patients 
with concomitant inflammatory bowel disease (p = 0.033,
OR 4.18).  Conclusion: The  IL2/IL21 region may be one of the 
highly suggestive but so far rarely identified shared suscep-
tibility loci for PSC and UC.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Primary biliary cirrhosis (PBC) and primary scleros-
ing cholangitis (PSC) are chronic cholestatic liver diseas-
es characterized by an immune-mediated destruction of 
the biliary system, resulting in biliary fibrosis, cirrhosis, 
and finally chronic liver failure  [1, 2] . PBC is deemed to 
be a model autoimmune disease due to its striking female 
predominance and the existence of a disease-specific au-
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 Abstract 
 Background/Aims: The chromosome 4q27 region harbor-
ing  IL2 and  IL21 is an established risk locus for ulcerative coli-
tis (UC) and various other autoimmune diseases. Considering 
the strong coincidence of primary sclerosing cholangitis 
(PSC) with UC and the increased frequency of other autoim-
mune disorders in patients with primary biliary cirrhosis 
(PBC), we investigated whether genetic variation in the  IL2/
IL21 region may also modulate the susceptibility to these 
two rare cholestatic liver diseases.  Methods: Four strong-
ly UC-associated single nucleotide polymorphisms (SNPs) 
within the  KIAA1109/TENR/IL2/IL21 linkage disequilibrium 
block were genotyped in 124 PBC and 41 PSC patients. Con-
trol allele frequencies from 1,487 healthy, unrelated Cau-
casians were available from a previous UC association
study.  Results: The minor alleles of all four markers were as-
sociated with a decreased susceptibility to PSC (rs13151961: 
p = 0.013, odds ratio (OR) 0.34; rs13119723: p = 0.023, OR 0.40; 
rs6822844: p = 0.031, OR 0.41; rs6840978: p = 0.043, OR 0.46). 
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toantibody directed against the E2 subunit of the mito-
chondrial pyruvate dehydrogenase complex  [2] . In con-
trast, PSC may rather be caused by a dysregulated im-
mune response to bacterial or viral antigens entering the 
portal circulation due to increased permeability of the 
colonic mucosa – or by activated T lymphocytes under-
going enterohepatic circulation  [1] . Consistent with that, 
there is a strong association of PSC with inflammatory 
bowel disease (IBD). In western countries, between 53 
and 98% of PSC patients have concomitant IBD, primar-
ily ulcerative colitis (UC)  [3, 4] . Conversely, the preva-
lence of PSC among patients with UC ranges from 2 to 
7.6%  [3, 4] .
 However, while recent genome-wide association stud-
ies have revealed several overlapping susceptibility loci 
(reviewed in  [5] ) for a variety of immune-mediated dis-
eases including PBC  [6] , the search for common genetic 
risk factors for UC and PSC provided results that were 
well behind expectations. Only 2 of 15 established UC loci 
tested, namely G protein-coupled bile acid receptor 1 
 ( GPBAR1 ; 2q35) and macrophage-stimulating 1 ( MST1 ; 
3p21), showed moderate association with PSC in a Scan-
dinavian cohort  [7] . Apart from  glypican 6  ( GPC6 ; 13q31), 
which is not implicated in UC, the first genome-wide as-
sociation study in PSC failed to detect susceptibility loci 
outside the HLA complex on chromosome 6p21, whose 
role in PSC susceptibility has already been extensively 
studied  [7] .
 Given the limited data on shared susceptibility loci for 
UC and PSC, we aimed to evaluate the role of four ge-
netic polymorphisms in the  IL2/IL21 region (rs13151961, 
rs13119723, rs6822844 and rs6840978) in our cohort of 
PSC patients on a candidate gene basis. These polymor-
phisms are strongly associated with UC  [8–11] , but were 
not included in the above-mentioned genome-wide anal-
ysis  [7] and were not part of the 15 UC loci previously 
analyzed in PSC  [7] .
 The association of the IL2/IL21 region on chromo-
some 4q27 with celiac disease  [12] , type 1 diabetes  [13–
15] , rheumatoid arthritis  [14, 16, 17] , psoriatic arthritis 
 [18] , juvenile idiopathic arthritis  [19, 20] , systemic lupus 
erythematosus  [17, 21] , Sjögren’s syndrome  [17] and 
Grave’s disease  [15] suggests this region as a general au-
toimmune risk locus and makes it also an interesting can-
didate locus for PBC. The frequency of classic autoim-
mune diseases is increased in both PSC patients and PBC 
patients and their first-degree relatives  [22, 23] .
 In order to examine a potential association with PBC 
or PSC, we determined allele frequencies and haplotype 
frequencies of the four aforementioned  IL2/IL21 -poly-
morphisms in two well-characterized patient cohorts 
and compared them with a large group of healthy control 
subjects.
 Methods 
 Patients and Control Subjects 
 The study included 124 PBC and 41 PSC patients of European 
Caucasian descent. All patients were recruited at Grosshadern 
University Hospital, Munich, Germany. PBC was diagnosed us-
ing standard criteria: presence of anti-mitochondrial antibodies 
(AMA) in serum, elevation of cholestatic liver enzymes and/or 
disease-specific hepatic histopathology  [24] . The diagnosis of 
PSC was based on biochemical changes consistent with chronic 
cholestasis in coincidence with characteristic intrahepatic and/or 
extrahepatic alterations of the bile ducts shown by endoscopic ret-
rograde or magnetic resonance cholangiopancreatography  [25] . 
Detailed clinical data for all patients were obtained by analysis of 
patient charts.
 Genotyping results of 1,487 healthy unrelated European Cau-
casian controls for the herein tested SNPs in the  IL2/IL21 region 
were available from a previous study investigating their role in UC 
 [10] . The epidemiological characteristics of the three study groups 
are given in  table 1 . Written informed consent was obtained from 
all participants. Ethical approval was given by the Ethics Com-
mittee of the Medical Faculty of Ludwig Maximilian University, 
Munich. The study adhered to the Ethical Principles for Medical 
Research Involving Human Subjects of the Helsinki Declaration. 
All data were stored in a coded, anonymized database.
 SNP Selection and Genotyping 
 A roughly 440 kb-long region of pronounced linkage dis-
equilibrium on chromosome 4q27 comprising the four genes 
 KIAA1109, TENR, IL2, and  IL21 has initially been identified as 
the strongest susceptibility locus for celiac disease outside the 
HLA complex by a genome-wide association scan  [12] . The four 
SNPs rs13151961 (A 1 G), rs13119723 (A 1 G), rs6822844 (G 1 T), 
and rs6840978 (C 1 T) were the strongest disease associated poly-
morphisms within this gene cluster in the initial celiac disease 
scan and all showed highly significant association with UC in two 
independent studies  [8, 10] . Therefore, we chose these four SNPs 
to determine whether genetic variation in the chromosome 4q27 
region is also implicated in the susceptibility to PBC or PSC.
 Venous EDTA blood samples were obtained from all patients 
and genomic DNA was isolated from peripheral blood leukocytes 
by using the DNA Blood Mini Kit (Qiagen, Hilden, Germany). 
Genotyping was performed by melting curve analysis in a Light-
Cycler  480 instrument (Roche Diagnostics, Mannheim, Ger-
many) as described previously  [10] and is specified in the online 
suppl. appendix 1 (www.karger.com/doi/10.1159/000321619). The 
overall genotyping success rate was 99.0% for controls, 99.4% for 
PBC and 100% for PSC patients.
 Statistical Analysis 
 Before statistical analysis, conformance with the Hardy-Wein-
berg equilibrium was computed for all markers. The genotype 
frequencies predicted by allele frequencies were compared to the 
observed genotypes. Therefore, an exact test integrated in Haplo-
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view 4.2  [26] was applied to the combined dataset of all three co-
horts. Haploview provided r 2 linkage disequilibrium (LD) statis-
tics for the four tested polymorphisms and was further used for 
the evaluation of haplotype counts and frequencies. It analyzes 
haplotype association by   2 testing and performs permutations to 
correct for multiple testing. Since in the PSC cohort, some haplo-
type counts were 5 or less, we show Fisher’s exact test p values in 
brackets in table 3. For single marker association analysis, case 
and control allele counts – or genotypes where indicated – were 
compared with Fisher’s exact test. Blaker’s exact test  [27] was used 
where denoted by  P BL . A two-tailed p  ! 0.05 was considered sta-
tistically significant. Odds ratios (ORs) were calculated with a 
95% confidence interval (CI) and statistical power of the odds ra-
tios was defined with SNP_tools  [28] . Fisher’s exact test was per-
formed with SPSS 15.0 software (SPSS Inc., Chicago, Ill., USA). 
Blaker’s exact test was computed by R (version 2.11.1) software (R 
Development Core Team, Vienna, Austria). Student’s t test was 
applied for quantitative variables and was calculated with Micro-
soft Excel (Microsoft Corp., Redmond, Wash., USA).
 Results 
 Patient Characteristics 
 The main clinical characteristics of the PBC and PSC 
patients are shown in  table 1 . One hundred and twenty-
one (97.6 %) of the 124 PBC patients were female reflect-
ing the known substantial female preponderance of this 
disease. Ten (8.1%) of the PBC patients had an autoim-
mune hepatitis (AIH) overlap syndrome. The mean age 
at diagnosis of PBC was 48.9  8 9.6 SD years. Histological 
staging was available for 64 of the 124 PBC patients. Of 
these, 23 (35.9%) showed advanced disease (stage III–IV), 
whereas 41 (64.1%) were in stage I or II. Fifteen of the 124 
PBC patients (12.1%) had already undergone liver trans-
plantation. This percentage was similar in the PSC group 
(4 of 41 patients; 9.8%). Malignancies were seen in both 
groups: 1 PSC patient had been diagnosed for cholangio-
carcinoma, and 2 PBC patients exhibited hepatocellular 
carcinoma.
 Twenty-three PSC patients (56.1%) had concomitant 
IBD (UC, n = 21; Crohn’s disease, n = 1; indeterminate 
colitis, n = 1). The mean age at diagnosis of IBD (23.2  8 
15.3 SD years) was significantly lower than the age at di-
agnosis of PSC (31.7  8 14.9 SD years; p = 0.041). In 19 of 
23 PSC patients with concomitant IBD (82.6%), the diag-
nosis of IBD preceded the onset of PSC or was made in 
the same year. Three PSC patients had a PSC-AIH overlap 
syndrome. As noted in an earlier study  [29] , the male pre-
dominance in PSC (overall men to women ratio approxi-
mately 3: 2) was especially pronounced in the subgroup 
with IBD (78.3% male). In the subgroup with PSC alone, 
the sex ratio was more balanced (55.6% male).
 SNPs in the KIAA1109-TENR-IL2-IL21 Gene Cluster 
Are Associated with PSC but Not PBC Susceptibility 
 The genotype frequencies of all four tested genetic 
polymorphisms were in accordance with the Hardy-
Weinberg equilibrium. The minor alleles of the four 
SNPs rs13151961 (p = 0.013), rs13119723 (p = 0.023), 
rs6822844 (p = 0.031) and rs6840978 (p = 0.043) were as-
sociated with a decreased susceptibility to PSC in our pa-
tient cohort ( table 2 ). For the most strongly PSC-associ-
ated SNP, rs13151961, the minor allele frequency was 
0.061 in PSC patients, whereas it was 0.162 in controls. 
Table 1.  Clinical characteristics of the study population
PBC (n = 124) PSC (n = 41) Controls (n = 1,487)
Male, n (%) 3 (2.4) 28 (68.3) 928 (62.4)
Female, n (%) 121 (97.6) 13 (31.7) 559 (37.6)
Concomitant IBD, n (%)
Ulcerative colitis, n (%)
Crohn’s disease, n (%)
Indeterminate colitis, n (%)
2 (1.6)
1 (0.8)
1 (0.8)
0
23 (56.1)
21 (51.2)
1 (2.4)
1 (2.4)
AIH overlap syndrome, n (%) 10 (8.1) 3 (7.3)
Mean age 8 SD (range), years 63.9812.1 (19–89) 40.4813.5 (21–92) 46.0810.7 (18–71)
Mean age at diagnosis 8 SD (range), years 48.989.6 (19–70) 31.7814.9 (13–86)
Mean age at diagnosis of concomitant
IBD 8 SD (range), years 48.0822.6 (32–64) 23.2815.3 (10–82)
Liver transplantation, n (%) 15 (12.1) 4 (9.8)
Cholangiocarcinoma, n (%) 0 1 (2.4)
Hepatocellular carcinoma, n (%) 2 (1.6) 0
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The odds ratios for the minor allele ranged from 0.34 for 
rs13151961 to 0.46 for rs6840978. The demonstrated odds 
ratios of  ! 1.0 suggest protective effects of the minor al-
leles on PSC susceptibility similar to the association ob-
served for other immune-mediated diseases  [8–12, 14, 16, 
17, 20] . In line with that, homozygosity for the major al-
lele was positively associated with development of PSC 
when examining rs13151961 (p = 0.014, OR 3.03, 95% CI 
1.18–7.76), rs13119723 (p = 0.036, OR 2.53, 95% CI 1.06–
6.06) or rs6822844 (p = 0.037, OR 2.45, 95% CI 1.02–5.86).
 In contrast, we did not find any significant association 
with PBC concerning allele or genotype frequencies (see 
 table 2 for allele frequencies).
 Haplotypes Formed by the SNPs within the 
KIAA1109-TENR-IL2-IL21 Linkage Disequilibrium 
Block Are Associated with Susceptibility to PSC 
 The four SNPs in the  KIAA1109-TENR-IL2-IL21 gene 
cluster are in accentuated linkage disequilibrium to each 
other ( fig. 1 ). The aforementioned association of the sin-
gle markers with PSC prompted us to evaluate, whether 
single haplotypes formed by the SNPs are also associated 
with susceptibility to PSC or PBC. First, the four SNPs 
were configured in a single haplotype block. Three hap-
lotypes exhibiting an overall frequency  1 0.01 were ob-
served ( table 3 ). As expected, a haplotype consisting of 
the four minor alleles was significantly associated with a 
Table 2.  Chromosome 4q27 markers in PBC, PSC and healthy controls
Marker Minor
allele
PBC (n = 124) PSC (n = 41) Controls (n = 1, 487)
MAF p valuea OR [95 % CI] Power MAF p valuea OR [95 % CI] Power MAF
rs13151961 G 0.154 0.857 0.94 [0.66–1.35] 0.05 0.061 0.013 0.34 [0.14–0.83] 0.65 0.162
rs13119723 G 0.169 0.859 1.03 [0.73–1.45] 0.04 0.073 0.023 0.40 [0.17–0.92] 0.58 0.166
rs6822844 T 0.150 0.718 0.92 [0.64–1.32] 0.06 0.073 0.031 0.41 [0.18–0.95] 0.55 0.161
rs6840978 T 0.195 0.800 1.04 [0.75–1.45] 0.04 0.098 0.043 0.46 [0.22–0.97] 0.53 0.189
Minor allele frequencies (MAF), allelic test p values, odds ratios (OR, shown for the minor allele) with 95% CIs and power of odds 
ratio 95% CI. Significant associations are highlighted in bold.
a Two-tailed p values were calculated by Fisher’s exact test analysis of allele counts.
Table 3.  Chromosome 4q27 haplotypes in PBC, PSC and healthy controls
Haplotype
block
Allelic
order
PBC (n = 124) PSC (n = 41) C ontrols
HF p valuea OR [95% CI] P100,000b HF p valuea OR [95% CI] P100,000b (n = 1,487 )
1 2 3 4 AAGC 0.791 0.66 0.93 [0.68–1.29] 0.96 0.878 0.089 (0.092) 1.77 [0.91–3.46] 0.28 0.802
GGTT 0.148 0.77 0.95 [0.66–1.37] 0.97 0.049 0.0084 (0.0048) 0.28 [0.10–0.77] 0.035 0.155
AAGT 0.045 0.17 1.56 [0.82–2.96] 0.39 0.037 0.70 (0.73) 1.25 [0.39–4.04] 1 0.029
1 2
(KIAA1109)
AA 0.836 0.99 1.00 [0.70–1.42] 1 0.927 0.027 (0.023) 2.49 [1.08–5.75] 0.054 0.836
GG 0.148 0.57 0.90 [0.62–1.30] 0.84 0.061 0.014 (0.013) 0.34 [0.14–0.84] 0.042 0.161
2 3
(IL2)
AG 0.833 0.94 1.02 [0.72–1.44] 0.99 0.915 0.046 (0.050) 2.18 [1.00–4.75] 0.071 0.831
GT 0.150 0.79 0.95 [0.66–1.37] 0.94 0.061 0.018 (0.013) 0.35 [0.14–0.87] 0.045 0.157
3 4
(IL21)
GC 0.805 0.88 0.98 [0.70–1.35] 1 0.890 0.063 (0.064) 1.92 [0.95–3.86] 0.23 0.809
TT 0.150 0.72 0.94 [0.64–1.35] 1 0.061 0.016 (0.013) 0.34 [0.14–0.85] 0.040 0.159
GT 0.045 0.22 1.49 [0.79–2.83] 0.40 0.037 0.75 (0.74) 1.20 [0.37–3.87] 1 0.031
Hap lotype frequencies (HF), p values, odds ratios (OR) with 95% CIs and power of odds ratio 95% CI. 1 = rs13151961; 2 = rs13119723; 
3 = rs6822844; 4 = rs6840978. Significant associations are highlighted in bold and suggestive ones in italics. For each block, all haplo-
types with an overall frequency >1% were examined. a Individual two-tailed p values from 2 test analysis of haplotype counts (for PSC, 
Fisher’s exact test p values in brackets). b Permutated p values (100,000 permutations).
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decreased susceptibility to PSC (p = 0.0084, OR 0.28, 95% 
CI 0.10–0.77). A similar haplotype including these four 
alleles has also a protective effect on UC  [10] .
 In order to better represent the different candidate 
genes within the chromosome 4q27 region, we analyzed 
three further haplotypes. One encompassed rs13151961 
and rs13119723 within  KIAA1109 , the two SNPs with
the strongest linkage disequilibrium. One included 
rs13119723 and rs6822844, which distantly surround  IL2 , 
and the third one comprised rs6822844 and rs6840978 
next to  IL21 ( fig. 1 ). All haplotypes formed by the corre-
sponding minor alleles were observed with a significant-
ly lower frequency in PSC patients compared to the 
healthy controls ( table 3 ). In case of the  IL2 and  KIAA1109 
haplotypes, the assembled major alleles showed a signifi-
cant positive association with PSC vice versa.
 In contrast, we did not detect PBC-associated haplo-
types ( table 3 ).
 KIAA1109-TENR-IL2-IL21 Variants Are Associated 
with PSC Independently of Concomitant IBD 
 The herein studied genetic variants are associated 
with UC, and there is also some evidence for an associa-
tion with Crohn’s disease  [8–11] . PSC-IBD is considered 
a distinct IBD phenotype on its own  [3] . The colitis as-
sociated with PSC is usually mild and is characterized 
by a more severe right-sided disease, rectal sparing and 
backwash ileitis  [30] . However, since 23 of our 41 PSC 
patients (56.1%) had concomitant IBD, we aimed to in-
vestigate whether the observed association with PSC is 
independent of a co-affection with IBD. Therefore, the 
haplotypes depicted in  table 3 and all four single mark-
ers were tested for association with the 18 PSC cases 
without IBD. Despite the limited sample size, the haplo-
type containing the four major alleles of rs13151961, 
rs13119723, rs6822844 and rs6840978 showed signifi-
cant association with PSC ( P BL = 0.033, OR 4.18, 95%
CI 1.12–24.51). Of the further haplotypes, the one en-
compassing rs6822844 and rs6840978 next to  IL21 was 
associated with PSC without IBD when combining the 
two major alleles ( P BL = 0.033, OR 4.02, 95%CI 1.08–
23.53).
 With regard to the single markers, rs6840978 did
not lose significance when excluding the patients with 
accompanying IBD ( P BL = 0.034, OR 0.25, 95% CI 0.04–
0.94; OR shown for the minor allele). Homozygosity
for the major allele of rs6840978 was a risk factor for 
PSC without IBD ( P BL = 0.045, OR 4.11, 95 % CI 1.05–
25.13).
 Discussion 
 Here, we demonstrate for the first time that the estab-
lished UC risk locus on chromosome 4q27  [8–11] is asso-
ciated with susceptibility to PSC.
 The contribution of genetic factors to the pathogenesis 
of PSC is highlighted by a nearly 100-fold higher preva-
lence of this disorder in first-degree relatives of PSC pa-
tients compared with the general population  [31] . Ac-
cording to a recent Swedish study  [32] , the hazard ratio 
for UC among first-degree relatives of PSC patients is also 
raised. Even relatives of PSC patients without IBD have a 
more than seven times increased risk of developing UC, 
which strongly suggests the existence of shared genetic 
susceptibility genes for PSC and UC  [32] .
 However, to date, only two other loci have been de-
scribed which confer susceptibility to both of these epi-
demiologically tightly linked diseases. Of 15 known UC 
loci tested so far, only  GPBAR1 and  MST1 showed asso-
ciation with overall PSC susceptibility even in a group 
where the proportion of concomitant IBD was 81%  [7] . Of 
these two, only one  (GPBAR1) was further associated 
with PSC without IBD in the corresponding subgroup of 
77 PSC patients without IBD  [7] .
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 Fig. 1. Overview over the chromosome 4q27 region. The 439-kb 
section between rs13151961 and rs6840978 is shown, with genes 
and LD statistics (r 2 ) calculated from the combined dataset of 
controls, PBC, and PSC patients using Haploview 4.2. 
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 Interestingly, the same polymorphisms in the
 KIAA1109-TENR-IL2-IL21 linkage disequilibrium block 
investigated are also associated with a variety of other 
immune-mediated diseases. Especially rs6822844 has 
been extensively studied. It has been associated with ce-
liac disease  [12] , UC  [8–11] , rheumatoid arthritis  [14, 16] , 
type 1 diabetes  [14] , psoriatic arthritis  [18] , juvenile idio-
pathic arthritis  [19, 20] , systemic lupus erythematosus 
 [17] and Sjögren’s syndrome  [17] .
 In all of these diseases, like in PSC, the minor allele 
frequency of rs6822844 is significantly decreased in cases 
suggesting protective effects of the minor allele on auto-
immune disease susceptibility. On the other hand, the 
‘wild-type’ major allele is a risk factor for the develop-
ment of autoimmunity. 
 Insulin-dependent diabetes 3  (IDD3) , the correspond-
ing locus in mice, also harbors the four genes  KIAA1109 , 
 TENR ,  IL2 and  IL21 . It is the strongest non-MHC linked 
susceptibility locus for type 1 diabetes in the nonobese 
diabetic (NOD) mouse. Several detailed studies have 
 addressed the functional impact of disease-associated 
 alleles within this autoimmunity locus using the NOD 
mouse model  [33–35] . Naturally occurring susceptibility 
alleles correlate with an approximately twofold reduction 
in IL-2 expression and hence impair the function of 
CD4+ CD25+ regulatory T cells, which are critical for 
maintaining immune homoeostasis  [34] . In contrast, 
protective  IDD3 allelic variants promote the expansion 
and suppressive functions of CD4+Foxp3+ regulatory T 
cells and restrain the proliferation and IL-17 production 
of pro-inflammatory CD4+ T cells by boosting IL-2 ex-
pression  [33] . IL-2 is essential for TGF-  to convert naive 
CD4+CD25- cells to CD25+Foxp3+ regulatory T cells 
 [36] and via STAT5 constrains the generation of Th17 
cells  [37] , which are implicated in the pathogenesis of au-
toimmune diseases.
 Mice with a disrupted  IL2  gene develop an UC-like 
disease  [38] . Defective IL-2 production has also been de-
scribed for freshly isolated liver derived T lymphocytes 
from PSC patients. Compared with patients with PBC, 
AIH, or normal controls, significantly higher levels of tu-
mor necrosis factor (TNF)-  and IL-1  but lower levels 
of IL-2, IL-10, and interferon-  were found in the super-
natants of mitogen-stimulated lymphocyte cultures  [39] . 
Like IL-2  [40] , IL-10 is considered an anti-inflammatory 
cytokine promoting immune tolerance  [41] .
 Another study on the role of autoimmunity-related al-
leles in  IDD3 , the mouse homologue for human chromo-
some 4q27, indicates that a loss of locus parity between 
 IL2 and  IL21 decreases IL-2 mRNA stability and ensures 
high IL-21 production as a basis for autoimmunity  [35] . 
IL-21 plays a key role in Th17 differentiation  [42] , leads to 
a down-regulation of FOXP3 expression in CD4+ T cells 
 [43] and renders CD4+CD25– T cells resistant to regu-
latory T-cell-mediated suppression  [44] . The opposing 
functions of IL-2 and IL-21 in tolerance and immunity 
underpin the disastrous effect of a dysregulated expres-
sion of these two cytokines.
 Unlike in PSC, we could not detect any impact of
the  KIAA1109-TENR-IL2-IL21 SNPs on susceptibility to 
PBC. This finding is in line with a recent genome-wide 
association study comprising these SNPs  [6] . Taking into 
account that for rs13151961, our study would have had a 
98% power to reveal a difference in minor allele frequen-
cy, like it was observed in PSC, it is unlikely that genetic 
variation in the  IL2/IL21 region plays a major role in the 
pathogenesis of PBC. However, a minor effect on PBC 
susceptibility cannot be excluded, since the power of our 
study to detect a lower difference in minor allele frequen-
cy of 5%, for instance, for rs13151961, was only 51%.
 The aforementioned recent genome-wide analysis
in PBC  [6] could find an association with rs6838639
on chromosome 4q27 about 200 kb away from the
 KIAA1109-TENR-IL2-IL21 linkage disequilibrium block 
in its discovery panel. This finding, however, could not 
be verified in two replication cohorts  [6] .
 In contrast to  IL2 and  IL21, KIAA1109 is a predicted 
gene of largely unknown function  [12] .  TENR (testis nu-
clear RNA-binding) expression is restricted to testes 
making it an unlikely disease gene for PSC  [12] .
 In conclusion, we here provide first evidence that the 
 KIAA1109-TENR-IL2-IL21  linkage disequilibrium block 
represents a shared susceptibility locus for UC and PSC. 
 IL2 and  IL21 are the likely disease genes. Further replica-
tion studies in larger cohorts are required to confirm this 
disease locus.
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